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© 2009 The Japan Society of Histochemistry and Cy- The elastic system fibers comprise oxytalan, elaunin and elastic fibers, which differ in their
relative microfibril and elastin content. Human periodontal ligaments (PDL) contain only
oxytalan fibers (pure microfibrils) among them. Since fibulin-5 regulates the organization of
elastic fibers to link the fibers to cells, we hypothesized that fibulin-5 may contribute to the
formation of oxytalan fibers. We used siRNA for fibulin-5 in PDL cell culture to examine the
extracellular deposition of fibrillin-1 and -2, which are the major components of microfibrils.
Fibulin-5 was labeled on microfibrils positive for fibrillin-1 and -2. Fibulin-5 suppression
reduced the level of fibrillin-1 and -2 deposition to 60% of the control level. These results
suggest that fibulin-5 may control the formation of oxytalan fibers, and play a role in the
homeostasis of oxytalan fibers.
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I. Introduction
The elastic system fibers that give tissue flexibility and
extensibility have two components: an amorphous core of
cross-linked elastin and a peripheral mantle of microfibrils
[12]. Elastic fiber formation is thought to begin with the for-
mation of a scaffold of microfibrils on which the elastin is
deposited. Depending on the relative proportions of micro-
fibrils and elastin, elastic system fibers can be classified
into three types: oxytalan, elaunin and elastic fibers. Inter-
estingly, in the periodontal ligaments (PDL), only oxytalan
fibers, which are pure microfibrils, are identified, whereas
all three types of fibers are present in the gingiva [5, 17]. In
PDL, oxytalan fibers are thought to have some functional
roles, such as supporting of vascular orientation and regula-
tion of vascular flow [18]. In our series of studies [20], we
have demonstrated that human PDL fibroblasts express
fibrillin-1 and -2 (the major components of oxytalan fibers)
without expression of tropoelastin (precursor of mature
elastin). By PDL fibroblast culture, we clearly showed
that pure oxytalan fibers are formed in cell/matrix layers.
Furthermore,  activated  matrix  metalloproteinase-2  con-
trols the degradation of fibrillin-2 to maintain a precise
amount of oxytalan fibers in PDL [25]. However, precisely
how oxytalan fibers develop remains unclear.
Fibulins are extracellular glycoproteins, which are as-
sociated with elastic fibers [1, 19]. They function as molec-
ular bridges, thus contributing to assembly and organization
of the extracellular matrix. Fibulin families comprise six
glycoproteins, which are characterized by a C-terminal
fibulin-type globular domain preceded by cbEGF (calcium-
binding epidermal growth factor)-like modules. Among
them, fibulin-5, a 55-kDa glycoprotein, has been reported to
have a relationship with elastic system fibers [16, 27].
Fibulin-5 can interact with both fibrillin-1 and tropoelastin
[7, 8], and we have reported that the fibulin-5 gene is con-
trolled by the tropoelastin gene [23]. Moreover, experiments
using genetically targeted mice have shown that fibulin-5
is necessary for the biogenesis of elastic fibers [30]. There-
fore, fibulin-5 is thought to be an adaptor for bindingHisanaga et al. 152
tropoelastin to microfibrils for the formation of elastic fibers
[10].
On the other hand, fibulin-5 expression is known to
be distributed even in elastin-free tissues [19]. However,
fibulin-5 has been assumed to play a role in elastic fiber
formation. We previously showed that human PDL fibro-
blasts express not only fibrillins but also fibulin-5 [23].
Therefore, based on the fact that fibulin-5 has the ability
to bind to fibrillin-1 [8], we hypothesized that fibulin-5 may
contribute to the formation of microfibrils in PDL. In the
present study we used a culture model of pure microfibrils
to investigate the role of fibulin-5 in the development of
microfibrils, and found that fibulin-5 co-localizes with
microfibrils and controls the biogenesis of microfibril
bundles.
II. Material and Methods
Cells and culture
The protocol for these experiments was reviewed and
approved by the Fukuoka Dental College Research Ethics
Committee, and informed consent was obtained from the
tissue donors.
PDL fibroblasts were isolated from three different
donors and cultured, as described previously [20]. Briefly,
connective tissues were obtained surgically from the PDL
molar teeth extracted for orthodontic reasons. After washing
in phosphate-buffered saline (PBS) supplemented with 100
units/ml penicillin and 100 μg/ml streptomycin (Roche
Diagnostics, Mannheim, Germany), the PDL tissues were
cut into small pieces, plated in petri dishes, and incubated
in Minimum Essential Medium (MEM) (Invitrogen, Grand
Island, NY, USA) supplemented with 10% newborn calf
serum (NCS; Invitrogen) at 37°C in humidified air con-
taining 5% CO2. When the outgrowth of the cells reached
confluence, they were harvested with 0.025% trypsin
(Invitrogen) in PBS, and transferred to plastic culture
dishes at a 1:4 split ratio. For experiments, the cells were
trypsinized and seeded at 1×106 cells/ml per 35-mm culture
dish (Corning Incorporated, Corning, NY, USA) in MEM
supplemented with 10% NCS, 100 units/ml penicillin and
100 μg/ml streptomycin.
Immunoprecipitation
The cell culture medium was harvested and mixed with
proteinase inhibitor cocktail containing 5 mM ethylenedi-
aminetetraacetic acid, 50 μM N-ethylmaleimide, and 50 μM
phenylmethylsulfonyl fluoride. The medium of the PDL
fibroblast culture was incubated with anti-human fibrillin-1
polyclonal antibody (Elastin Products Co., Owensville, MO,
USA) or anti-human fibulin-5 polyclonal antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) in the presence
of 2% bovine serum albumin (BSA, fraction V; Sigma, St.
Louis, MO, USA) for 2 hr at 4°C. Protein G-agarose beads
(Pierce Biotechnology, Inc., Rockford, IL, USA), pre-
washed with MEM containing 2% BSA, were then added to
the sample-antibody mixture and incubated for 1 hr at 4°C.
Then the beads were collected by centrifugation and washed
five times extensively with MEM, changing the tube for the
last spin. The immunoprecipitated protein retained by the
washed beads was then eluted with a gel electrophoresis
loading buffer (1% sodium dodecyl sulfate, 10 mM Tris, 5%
glycerol, and 25% dithiothreitol, pH 7.0), and subjected to
4–12% polyacrylamide gel electrophoresis for western
blotting.
Small interference RNA (siRNA) design and transient 
transfection
siRNA for human fibulin-5 (Accession # NM_006329)
was designed and synthesized by Hokkaido System Science
Co., Ltd. (Sapporo, Japan). The synthesized siRNA corre-
sponded to the 1165–1190 coding region of fibulin-5. The
siRNA sequence for fibulin-5 was: sense 5'-GGCAGAGA
AUUUUACAUGCGGCAAAAG-3', antisense 3'-UACCG
UCUCUUAAAAUGUACGCCGUUU-5. Negative control
(scrambled order) was: sense 5'-CGGUCUAGACUAGC
GAGAUAAUAGAAG-3', antisense 3'-UAGCCAGAUCU
GAUCGCUCUAUUAUCU-5'. A sequence of the negative
control was designed as a randomized sequence of the 1165–
1190 coding region of fibulin-5. BLAST searches of the
database indicated that this siRNA is specific for fibulin-5,
and has no homology with other proteins. Transfection was
performed at 7 and 10 days of culture continuously. The
siRNA was transfected into PDL fibroblasts using the X-
treme GENE siRNA transfection reagent (Roche). First,
237.5 μl of OptiMEM medium/dish (Invitrogen) and 12.5
μl of the transfection reagent were preincubated for 10 min
at room temperature. During this time, 748 μl of OptiMEM
medium was mixed with 2 μl of 100 μM siRNA. The two
mixtures were then combined and incubated for 20 min at
room temperature to allow complex formation. The entire
mixture was added to the cells in one dish, resulting in a
final concentration of 200 nM for the siRNAs. After 12 hr
of incubation, the transfection medium was replaced with
fresh complete medium (MEM with 10% NCS). Mock
transfection of cultures with the transfection reagent alone
was used as a control. PDL fibroblasts were transfected
twice with the siRNA duplex (0, 50 and 200 nM), with a
72-hr interval, and harvested at 14 days.
Immunofluorescence
At 14 days of culture, PDL fibroblasts were fixed in
ice-cold 1% paraformaldehyde in PBS for 15 min. The cul-
ture dishes were rinsed with PBS, and treated with 6 M
guanidine-HCl, 20 mM Tris, and 50 mM dithiothreitol (pH
8.0) for 15 min. This treatment is effective to be exposed an
epitope of the cross-linked proteins. Nonspecific immuno-
reactivity was blocked with 1% bovine serum albumin in
PBS for 1 hr at room temperature. The cell layers were then
incubated for 2 hr at room temperature with the appro-
priate primary antibodies (polyclonal goat antibody against
fibulin-5 diluted 1:2000; Santa Cruz, and rabbit antibody
against fibrillin-1 and -2 diluted 1:2000; Elastin Products
Co.). Controls included the use of preimmune normalFibulin-5 Controls Microfibril Deposition 153
goat or rabbit IgG for the primary antibody incubation. We
had already confirmed the specificity of the fibrillin-1 and
fibrillin-2 antibodies as reported previously [20]. After
rinsing in PBS, the cells were incubated with Alexa Fluor®
568-labeled donkey anti-goat IgG1 antibody or Alexa
Fluor® 488 or 568-labeled goat anti-rabbit Ig (H+L) anti-
body (Invitrogen), diluted 1:2000 with blocking buffer,
for 1 hr at room temperature. In some cases, SYTOX®
Green (Molecular Probes) was added at 100 nM for nuclear
staining. Following a rinse in PBS, immunoreactivity was
observed using a confocal microscope (MRC-1024; Bio-
Rad, Hemel Hempstead, UK). For double immunostaining,
the cells were reacted sequentially with two different pri-
mary antibodies against fibulin-5, fibrillin-1 and -2 at 1:2000
dilutions. Then the cells were reacted with two secondary
antibodies (Alexa Fluor® 488-labeled goat anti-rabbit Ig
(H+L) and Alexa Fluor® 568-labeled donkey anti-goat
IgG1) in a 1:1 mixture.
Western blot analysis
At 14 days of culture, the cell/matrix samples were pre-
pared as described previously [16]. For detection of fibrillin-
1 and fibrillin-2, we partly separated matrix and cellular pro-
teins from the cell/matrix samples as described previously
[17].
The immunoprecipitates or the proteins (5 μg) were
subjected to electrophoresis on 4–12% NuPAGE Bis-Tris
gel (Invitrogen) for western blot analysis, as described pre-
viously [17]. A549 cell (human lung carcinoma) lysates
were used as the positive control for fibulin-5, which was
purchased from Santa Cruz Biotechnology (Santa Cruz).
The monoclonal fibrillin-1 antibody for the detection of
fibrillin-1 in the immunoprecipitates against fibrillin-1 was
purchased from NeoMarkers (Fremont, CA, USA). The pri-
mary antibodies used were those against fibulin-5, fibrillin-
1 and -2 at 1:5000 dilution, and β-actin at 1:2000 dilution.
Prestained molecular weight markers (Invitrogen) run on
each blot. Densitometric analysis of the signals was per-
formed using the Image J program (National Institutes of
Health, Bethesda, MD, USA) after finding the linear portion
by sequential dilution of the proteins. Small variations in
protein loading were corrected by normalization relative to
the intensity of the corresponding band of β-actin. Each
value presented is expressed as the mean±standard devia-
tion (SD) and all quantitative results represent at least
three independent analyses. The unpaired Student’s t-test
was used for analyzing differences between experimental
groups [6].
Northern blot analysis
Total RNA was prepared from the cultured PDL fibro-
blasts at 14 days using an RNeasy Mini Kit (Qiagen, Hilden,
Germany). One microgram of RNA was subjected to north-
ern blot analysis, which was performed as described previ-
ously [21]. The probes for recognition of human fibrillin-1
and -2 were generated as described previously [22]. The
RNA probe for β-actin was from Roche Molecular Bio-
chemicals. Densitometric analysis of the signals was also
performed using the Image J program. Small variations in
RNA loading were corrected by normalization relative to the
intensity of the corresponding band of β-actin probe.
III. Results
Fibulin-5 localization on microfibrils
We first investigated the specificities of the fibrillin-1,
fibrillin-2 and fibulin-5 antibodies. We had already con-
firmed the specificities of the fibrillin-1 and -2 antibodies as
reported previously [20]. Figure 1A shows the results of
western blotting carried out on PDL culture media using the
three antibodies. For fibrillin-1 and -2, each antibody labels
a single band at 350 kDa, whereas the fibulin-5 antibody
labels a single band at 55 kDa. To confirm that each of the
antibodies recognizes a distinct protein, we carried out
immunoprecipitation with fibrillin-1 antibody and fibulin-5
antibody from PDL culture media. The immunoprecipitated
materials were then analyzed by western blotting with each
of the three antibodies. It is clear from Figure 1B that immu-
noprecipitates with fibrillin-1 antibody were reasonably
recognized by fibrillin-1 antibody, and that the fibulin-5
anybody did not cross-react with the protein immunoprecip-
itated by fibrillin-1 antibody. Similarly, immunoprecipitates
with fibulin-5 antibody were not recognized by the fibrillin-
1 and fibrillin-2 antibodies (Fig. 1C). Therefore we con-
firmed the specificity of the three antibodies.
We next examined whether fibulin-5 was localized on
microfibrils (Fig. 2). The positive staining by fibrillin-1 and
fibrillin-2 were microfibril, which were observed as net-
works of fiber patterns. Fibulin-5 was labeled on fibrillins-1-
and -2-immunolabeled microfibrils of human PDL fibro-
blasts cultured for 14 days. Control immune serum produced
no labeling (not shown). The results show that fibulin-5 was
co-localized with microfibrils.
Fibulin-5 siRNA inhibits deposition of its protein
Next, in order to investigate the function of fibulin-5,
we used siRNA to suppress fibulin-5 expression. Densito-
metric analysis based on the western blot showed that when
200 nM siRNA was used for transfection, the siRNA effec-
tively reduced the level of fibulin-5 deposition to more
than 90% of that of the control (vehicle only) in the PDL
cell/matrix layers at 14 days (Fig. 3A). In contrast, scram-
bled siRNA had no effect on fibulin-5 deposition, and no
difference from the control was evident (data not shown),
proving that this siRNA was specific for fibulin-5.
The immunolabeling data also supported the data from
western blotting. With 200 nM siRNA-transfected cells,
fibulin-5 staining was diminished in comparison with the
control cells (Fig. 3B).
Decrease of microfibril assembly by knock-down of fibulin-5 
expression
To investigate the effect of fibulin-5 on microfibril as-
sembly, we transfected PDL fibroblasts with 200 nM fibu-Hisanaga et al. 154
Fig. 1. Characterization of anti-fibrillin-1, fibrillin-2 and fibulin-5 antibodies. (A) Immunoblotting of PDL culture medium against anti-fibrillin-
1 (left lane), anti-fibrillin-2 (middle lane) and anti-fibulin-5 (right lane) antibodies. Fibrilin-1, fibrillin-2 and fibulin-5 antibodies interact with
an estimated single protein. (B) Immunoblotting against anti-fibrillin-1 (left lane) and anti-fibulin-5 (right lane) antibodies following immuno-
precipitation of PDL culture medium using anti-fibrillin-1 antibody. The immunoprecipitates were reasonably recognized by fibrillin-1 anti-
body (arrowhead), and the fibulin-5 antibody did not cross-react with the immunoprecipitates. (C) Immunoblotting against anti-fibrillin-1 (left
lane), anti-fibrillin-2 (middle lane) and anti-fibulin-5 (right lane) antibodies following immunoprecipitation using anti-fibulin-5 antibody. The
immunoprecipitates were reasonably recognized by fibulin-5 antibody (arrow), and neither of the other two antibodies cross-reacted with the
immunoprecipitates.
Fig. 2. Immunolocalization of fibulin-5 to microfibrils. Double immunofluorescence of fibrillin-1/fibulin-5 and fibrillin-2/fibulin-5 in PDL
fibroblasts cultures. Human PDL fibroblasts were cultured for 14 days, then simultaneously labeled with fibrillin-1 (green), fibulin-5 (red), and
superimposition of both labels (upper panels). Similarly, the cells were labeled with fibrillin-2 (green), fibulin-5 (red) and superimposition
(lower panels). Bar=100 μm.Fibulin-5 Controls Microfibril Deposition 155
Fig. 3. Fibulin-5 siRNA suppresses deposition of its protein. PDL fibroblasts were cultured for 7 days, and then transiently transfected with 0,
50, 200 nM fibulin-5 siRNA for another 7 days. (A) cell/matrix lysates (5 μg) were analyzed by western blotting. Mock-transfected (vehicle
only) culture was used as a control (second lane). A549 cell lysates were used as fibulin-5-positive controls (first lane). β-actin was used as an
internal control in each lane. (B) PDL fibroblasts were immunolabeled with anti-fibulin-5 antibody (red). SYTOX® Green was used for nuclear
staining (green). Bar=100 μm.
Fig. 4. Immunodetection of fibrillin-1 and fibrillin-2 in cell/matrix samples from PDL fibroblasts. PDL fibroblasts were transiently mock-trans-
fected (lane 1), or transiently transfected with 200 nM siRNAs for fibulin-5 (lane 2). (A) Western blots of matrix and cellular samples of PDL
fibroblasts cultured for 14 days. Equal amounts of proteins (5 μg) were separated by SDS-PAGE and transferred to Immobilon-P membranes.
The blots were probed with anti-fibrillin-1 and anti-fibrillin-2 antibodies. Each antibody recognized a 350-kDa band (arrow). Densitometric
analysis of changes in the levels of matrix and cell samples of fibrillins-1 and -2 was conducted using Image J software, and the value for each
control sample were arbitrarily assigned a value of 100. The results are representative of three independent experiments. Data are presented as
the mean±standard deviation (*p<0.05). (B) Northern blots of RNA samples (1 μg) extracted from PDL fibroblasts at 14 days. (C) Immuno-
fluorescence staining was performed with anti-fibrillin-1 antibody (upper panels) and anti-fibrillin-2 antibody (lower panels). SYTOX® Green
was used for nuclear staining (green). Bar=100 μm.Hisanaga et al. 156
lin-5 siRNA. In matrix proteins at 14 days, densitometric
analysis of the western blot results identified a significant
decrease of fibrillin-1 and -2 to 62±8% and 55±8% of the
control, respectively. As expected, transfection with fibulin-
5 siRNA did not affect the amounts in cellular proteins
(Fig. 4A) and gene expression (Fig. 4B) of fibrillin-1 and -2.
Furthermore, immunostaining of fibrillin-1 and -2 showed
less intense labeling after transfection of 200 nM fibulin-5
siRNA (Fig. 4C).
IV. Discussion
In the present study using the RNA interference tech-
nique, we have demonstrated for the first time that fibulin-5
has an effect on the amounts of extracellular deposition of
fibrillin-1 and -2. Previously, exogenous fibulin-5 [7, 10] as
well as endogenous fibulinb-5 [11] was shown to be local-
ized on fibrillin-1-positive fibers, and their molecular inter-
actions have been demonstrated [8]. Fibrillins-1 and -2 are
the principle structural components of microfibrils [12], and
co-assemble in the same microfibril fibers [4, 13]. Many
researchers have focused on microfibrils as a template for
tropoelastin deposition. In general, it has been believed that
fibrillins-1 and -2 have overlapping function for elastic fiber
formation [3]. Fibrillin-2 is expressed earlier in development
than fibrillin-1 in elastin-rich tissues, and its expression is
correlated with elastic fiber formation [29]. In accordance
with these findings, we have demonstrated that gene expres-
sion of fibrillin-2 is correlated with that of tropoelastin [22],
and that fibrillin-2 is essential for elastic fiber formation
[24]. However, there are few experimental data on the
mechanism of pure microfibril development.
Oxytalan fibers, which consist of collections of micro-
fibrils, were first described in PDL [9]. In the PDL tissues,
the microfibrils as well as collagen fibers are important
matrix components for maintaining PDL homeostasis. In our
culture system, PDL fibroblasts express abundant fibrillin-1
and -2 without tropoelastin, which reflects the situation
in vivo. We have demonstrated the synthesis [20] and
degradation [25] of fibrillins in PDL fibroblasts culture.
The fibrillin-2 is crucial for microfibril formation [2]. How-
ever, the mechanism of microfibril development remains
unclear, as described above. Fibulin-5 can bind to fibrillin-1
and tropoelastin [8]. In the present study, we showed that
fibulin-5 was colocalized with fibrillin-2 as well as with
fibrillin-1. This result is noteworthy in view of the paucity
of information on the relationship between fibulin-5 and
pure microfibrils. We speculated that fibulin-5 functions
as not only a mediator between microfibrils and tropoelastin
but also in the biogenesis of pure microfibrils. In this study,
suppression of fibulin-5 inhibited microfibril deposition
by about 40% (fibrillins-1 and -2 were inhibited to almost
the same degree). The reason that decreases of deposition
occur, despite the absence of any difference in its gene ex-
pression and secretion, is thought to be due to either protein
degradation or regulation by outside molecules. We could
not detect degradation products of fibrillins in the culture
media and cell lysates (data not shown). Therefore, it is
thought to that fibulin-5 contributes microfibril deposition
directly or indirectly. Moreover, fibulin-5 binds to micro-
fibril-associated molecule, such as lysyl oxidase-like 1
[14], EMILIN-1 [28] and so on. Therefore, further study is
necessary to identify the molecule related with microfibril
assembly.
Fibulin-5 is an integrin (αvβ3,  αvβ5,  α5β1,  α4β1)
ligand [15, 16]. PDL fibroblasts express αvβ3 integrins at
least, and the αvβ3 integrin controls microfibril assembly
[26]. Therefore, fibulin-5 on the cell surface may play a role
in gathering the microfibrils located at the cell periphery.
In summary, we have demonstrated that fibulin-5 is
colocalized with microfibrils, and may regulate microfibril
formation. Our findings may provide new insights into the
homeostasis of oxytalan fibers.
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